Abstract:p53 not only functions as a transcription factor but also has a direct, apoptogenic role at the mitochondria. We have discovered that DNA damage-induced p53-Bcl2 binding is associated with decreased Bcl2-Bax interaction and increased apoptotic cell death in a mechanism regulated by Bcl2's flexible loop regulatory domain (FLD), since purified p53 protein can disrupt the Bcl2/Bax complex by directly binding to a negative regulatory region of the FLD (amino acids [aa] 32 to 68). Deletion of the negative regulatory region (Delta 32-68) abolishes Bcl2-p53 binding and enhances Bcl2's antiapoptotic function. Conversely, removal of a positive regulatory region (aa 69 to 87) of the FLD, which contains the Bcl2 phosphorylation site(s) T69, S70, and S87, enhances Bcl2-p53 binding and significantly abrogates Bcl2's survival activity. The phospho-mimetic T69E/S70E/S87E (EEE) but not the nonphosphorylatable T69A/S70A/S87A (AAA) Bcl2 mutant displays a reduced capacity to bind p53 and potently inhibits p53-induced cytochrome c release from isolated mitochondria. Furthermore, the FLD-only aa32-87 and aa32-68 peptides but not the aa69-87 peptide can directly bind p53 in vitro. p53-induced cytochrome c release occurs through a mechanism involving Bax's integral insertion into the outer mitochondrial membrane. Either DNA damage to cells or expression of p53 selectively targeted to the mitochondria results in Bcl2-p53 binding followed by exposure of Bcl2's BH3 domain in association with inactivation of Bcl2's antiapoptotic function, indicating a conformational change in Bcl2 can occur upon direct ligation of p53. Thus, Bcl2's FLD contains both positive and negative regulatory regions which functionally regulate Bcl2's antiapoptotic activity by affecting Bax or p53 binding.

B1-induced Caspase-Independent Apoptosis in MCF-7 Cells is Mediated by Down-Regulation of Bcl-2 Via P53 Binding to P2 Promoter TATA Box

Inhibitory Effect of Bcl-2 on P53-Mediated Transactivation Following Genotoxic Stress

Bcl2'S Flexible Loop Domain Regulates P53 Binding and Survival

The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl.

A Conserved Mechanism for Binding of p53 DNA-Binding Domain and Anti-Apoptotic Bcl-2 Family Proteins

Anti-apoptosis Proteins Mcl-1 and Bcl-xL Have Different P53-Binding Profiles.

Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity

B1, a novel naphthalimide-based DNA intercalator, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation

Methyl Methanesulfonate Induces Apoptosis In P53-Deficient H1299 And Hep3b Cells Through A Caspase 2-And Mitochondria-Associated Pathway

The MDM2-binding Region in the Transactivation Domain of P53 Also Acts As a Bcl-X(L)-binding Motif.

Bcl-2 Constitutively Suppresses P53-Dependent Apoptosis in Colorectal Cancer Cells.

Regulation of Bax activation and apoptotic response to UV irradiation by p53 transcription-dependent and -independent pathways.

Effect Of Bcl-2 On Apoptosis And Transcription Factor Nf-Kappa B Activation Induced By Adriamycin In Bladder Carcinoma Biu87 Cells

The Apoptosis-Associated Gamma-Ray Response Of Bcl-X(L) Depends On Normal P53 Function

Mitochondrial p53 phosphorylation induces Bak-mediated and caspase-independent cell death.

Transcriptional down-regulation of Bcl-2 by vinorelbine: identification of a novel binding site of p53 on Bcl-2 promoter.

P53 Regulates Mitochondrial Membrane Potential Through Reactive Oxygen Species and Induces Cytochrome C-Independent Apoptosis Blocked by Bcl-2.

The DNA binding proteins of bcl-2 regulatory region in apoptosis of mouse fibroblast

Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: A derivative of tetrandrine.

PI3K/AKT Mediated P53 Down-Regulation Participates in CpG DNA Inhibition of Spontaneous B Cell Apoptosis

Protein Phosphatase 2A Suppresses Bcl2’s Antiapoptotic Function by Regulating Bcl2-p53 Interaction